Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of novel oral polio vaccine type 2 in infants and young children in The Gambia
PACTR202010705577776Phase 3Completed
- Sponsor
- PATH
- Start
- Jan 2021
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of nOPV2, sponsored by PATH. Started Jan 2021; status: completed.
02
Drugs
nOPV2
Beyond the preview
Go deeper on PACTR202010705577776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202010705577776.